# Intramuscular Diclofenac in the Prevention of Post-ERCP Pancreatitis

> **NCT01717599** · NA · COMPLETED · sponsor: **Yonsei University** · enrollment: 343 (actual)

## Conditions studied

- Post ERCP Pancreatitis

## Interventions

- **DRUG:** Diclofenac
- **DRUG:** normal saline

## Key facts

- **NCT ID:** NCT01717599
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08-29
- **Primary completion:** 2013-08-28
- **Final completion:** 2013-08-28
- **Target enrollment:** 343 (ACTUAL)
- **Last updated:** 2021-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01717599

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01717599, "Intramuscular Diclofenac in the Prevention of Post-ERCP Pancreatitis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01717599. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*